Related Experiment Videos
[Adrenomedullin and related peptides]
1First Department of Internal Medicine, Miyazaki Medical College, Japan.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|October 30, 1998
Summary
Adrenomedullin (AM) and PAMP are key peptides influencing blood pressure. Their elevated levels in cardiovascular diseases suggest a role in circulatory homeostasis, offering new research avenues.
Area of Science:
- Biochemistry
- Endocrinology
- Cardiovascular Physiology
Context:
- Adrenomedullin (AM), a hypotensive peptide, was discovered in human pheochromocytoma.
- Proadrenomedullin N-terminal 20 peptide (PAMP) is a related hypotensive peptide derived from proadrenomedullin.
- AM exhibits potent, long-lasting vasodilator effects across various vascular systems.
Purpose:
- To review recent advancements in Adrenomedullin (AM) research.
- To highlight the significance of AM and PAMP as vasoactive peptides.
- To explore their role in novel circulatory homeostasis mechanisms.
Summary:
- AM and PAMP are widely distributed, with AM mRNA highly expressed in cardiovascular tissues, suggesting paracrine/autocrine functions.
- Elevated plasma concentrations of AM and PAMP are observed in cardiovascular diseases like hypertension and heart failure.
- These peptides are crucial for understanding basic physiological mechanisms of circulatory control.
Impact:
- Elucidating the physiological roles of AM and PAMP can lead to new insights into blood pressure regulation.
- Understanding AM and PAMP pathways may reveal novel therapeutic targets for cardiovascular diseases.
- This research contributes to defining a potential new system for circulatory homeostasis.